Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas (NCT03925428) | National Cancer Institute (NCI) | 2020-09-18 |
Track Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.